Exclusive: Medivation succumbs to pressure to explore sale – sources
The San Francisco-based company has agreed to open its books to both Pfizer Inc and Amgen Inc , those people said. The move comes less than two weeks after Sanofi made its approach public by publishing a letter to Medivation's chief executive David Hung that contained details of the offer.
